Just Published: "Jordan Pharmaceuticals & Healthcare Report Q4 2015"

From: Fast Market Research, Inc.
Published: Mon Sep 14 2015

The majority of Jordan's pharmaceuticals will remain sourced from abroad despite the impressive domestic manufacturing industry. Local drugmakers will continue to supply the market with generic medicines but higher value innovative drugs will continue to be supplied by multinationals . Significant counterfeit medicine circulation and economic and political instability in neighbouring Syria will weigh down the domestic pharmaceutical markets appeal to foreign investment.

Headline Expenditure Projections

Pharmaceuticals: JOD643mn (USD905mn) in 2014 to JOD683mn (USD962mn) in 2015; +6.3% in local currency terms and US dollar terms. Forecast unchanged from Q 3 15.

Full Report Details at
- http://www.fastmr.com/prod/1038286_jordan_pharmaceuticals.aspx?afid=301

Healthcare: JOD1.85bn (USD2.61bn) in 2014 to JOD1.97bn (USD2.77bn) in 2015; +6.2% in local currency terms and US dollar terms. Forecast in line with Q 3 15 .

Risk/Reward Index

In our Q415 Risk/Reward Index, Jordan moves up one place to 10th position out of 31 markets surveyed in the Middle East and Africa region, with a score of 46.9 out of 100. Generally speaking, although Jordan offers a relatively favourable investment environment in terms of risks, its small population size (of around seven million) will continue to limit pharmaceutical market growth.

Key Trends a nd Developments

The Council of Ministers in Jordan approved general sales tax exemptions amounting to JOD5.5mn (USD7.8mn) for special diabetes materials and drugs in June 2015.

In June 2015, airline Royal Jordanian signed a Memorandum of Understanding with the Jordan Hospitals Association to build a strategic partnership between the two bodies and coordinate with authorities involved in medical and therapeutic tourism.

Prime Minister Abdullah Ensour called for accelerating efforts to examine the means to provide comprehensive health insurance to all Jordanians in July 2015.

BMI Economic View

The Jordan Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Jordan Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Jordan pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Jordan, to test other views - a key input for successful budgeting and strategic business planning in the Jordanian pharmaceutical and healthcare market.
* Target business opportunities and risks in the Jordanian pharmaceutical and healthcare sector

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Romania Pharmaceuticals & Healthcare Report Q4 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q4 2015
- Peru Pharmaceuticals & Healthcare Report Q4 2015
- Latvia Pharmaceuticals & Healthcare Report Q4 2015
- Nigeria Pharmaceuticals & Healthcare Report Q4 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »